CATEGORIES

15.02.2017

15.02.2017 08:46

Magic Leap buys Dacuda’s 3D Division

Dacuda has sold its 3D division to an American high tech company. LinkedIn profiles and other information lead to the conclusion that the buyer is the VR unicorn Magic Leap.

13.02.2017

13.02.2017 07:54

Amicomed closes seed round

Launchpad Digital Health, a seed fund and accelerator for digital health based in San Francisco, announced it is leading seed round funding for Amicomed and four other companies. These companies have now begun its twelve-month in-house immersion program.

09.02.2017

09.02.2017 11:30

Pensionskasse investiert in Schweizer Startups

Vorsorgegelder für das Wachstum von morgen: Nach diesem Motto hat sich die Sammelstiftung NEST entschlossen, künftig direkt in Schweizer Startups zu investieren. Dazu ist sie eine Partnerschaft  mit der Risikokapitalplattform investiere.ch eingegangen.

09.02.2017 08:54

Glycemicon raises CHF3.25 million

Glycemicon AG is a Swiss biotechnology company developing so called nutraceuticals for managing prediabetes, diabetes and obesity. Nutraceuticals are products naturally occurring in food sources with extra health benefits. The company will use the funds to conduct its first clinical trials.

09.02.2017 08:30

Twenty Thirty AG closes first financing round

Twenty Thirty is a Zug based startup focusing on creating a decentralized world by creating innovation centres using of Blockchain technology. The startup announced the closing of its first round for the development products and services and infrastructure for innovation Centres.

07.02.2017

07.02.2017 13:23

Prexton Therapeutics raises CHF31 million

Geneva based Prexton Therapeutics develops novel therapeutic compounds for the treatment of Central Nervous System (CNS) conditions. The Series B funding will be used to finance two phase II studies of Prexton’s lead product. Prexton Therapeutics was founded 2012 as a spin-off from Merck Serono.

02.02.2017

02.02.2017 11:30

Apidel SA closes third financing round

Apidel SA, a Geneva based pharmaceutical company, announced the completion of its third private financing round. The startup raised a significant amount of funds to accelerate and progress clinical and commercial development of its pipeline of therapeutic products.

Show All

Events

06.04.2017 08:00 - 22:00

Seedstars Summit 2017: The Entrepreneurship Forum For Emerging Markets SwissTech Convention Center, Lausanne

MEET US

Show All

Trainings

28.03.2017 12:00 - 14:00

Valuation of emerging life sciences companies Biopôle IV. Route de la Corniche 3, Floor -1, Room 1

Top viewed

Show All

Video

Tweets

Principal

24.03.2017
Editorial

Evidence of great potential

Partners

Contributors